Concepedia

Fumin Li

FL

12

Publications

264

Citations

12

H-Index

2000

Active since

Affiliations

Pharmaceutical Product Development (United States)(Current)

Agios Pharmaceuticals (United States)

Fumin Li is an author at Pharmaceutical Product Development (United States) specializing in medicine, engineering, and mass spectrometry.

ORCID

Top concepts

Publications per year

2000–2022

12

Publications

12

Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma

Fumin Li, Jinfeng Liao, Xiling Duan et al. · Journal of Cellular Biochemistry · 2018 · 36 citations

Quantitation of levodopa and carbidopa in rat plasma by LC–MS/MS: The key role of ion-pairing reversed-phase chromatography

Jingduan Chi, Yonghua Ling, Rand Jenkins et al. · Journal of Chromatography B · 2017 · 31 citations

, , +9

A Fully Automated and Validated Human Plasma LC–MS/MS Assay for Endogenous OATP Biomarkers Coproporphyrin-I and Coproporphyrin-III

Amanda King‐Ahmad, Sara Clemens, Ragu Ramanathan et al. · Bioanalysis · 2018 · 26 citations

Case Studies: The Impact of Nonanalyte Components on LC–MS/MS-Based Bioanalysis: Strategies for Identifying and Overcoming Matrix Effects

Fumin Li, Matthew Ewles, Mary Pelzer et al. · Bioanalysis · 2013 · 25 citations

, , +27

Assessing the impact of Diplocardia ornata on physical and chemical properties of compacted forest soil in microcosms

Felix Ponder, Fumin Li, Diann Jordan et al. · Biology and Fertility of Soils · 2000 · 23 citations

, , +6

Rows per page

1–5 of 12